全文获取类型
收费全文 | 3066篇 |
免费 | 231篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 77篇 |
妇产科学 | 69篇 |
基础医学 | 462篇 |
口腔科学 | 76篇 |
临床医学 | 327篇 |
内科学 | 631篇 |
皮肤病学 | 34篇 |
神经病学 | 182篇 |
特种医学 | 193篇 |
外国民族医学 | 2篇 |
外科学 | 383篇 |
综合类 | 53篇 |
一般理论 | 1篇 |
预防医学 | 233篇 |
眼科学 | 49篇 |
药学 | 322篇 |
中国医学 | 3篇 |
肿瘤学 | 203篇 |
出版年
2021年 | 28篇 |
2020年 | 23篇 |
2019年 | 26篇 |
2018年 | 53篇 |
2017年 | 40篇 |
2016年 | 42篇 |
2015年 | 46篇 |
2014年 | 62篇 |
2013年 | 97篇 |
2012年 | 113篇 |
2011年 | 121篇 |
2010年 | 82篇 |
2009年 | 70篇 |
2008年 | 114篇 |
2007年 | 128篇 |
2006年 | 119篇 |
2005年 | 114篇 |
2004年 | 119篇 |
2003年 | 108篇 |
2002年 | 109篇 |
2001年 | 95篇 |
2000年 | 97篇 |
1999年 | 107篇 |
1998年 | 47篇 |
1997年 | 45篇 |
1996年 | 38篇 |
1995年 | 30篇 |
1994年 | 31篇 |
1993年 | 28篇 |
1992年 | 76篇 |
1991年 | 88篇 |
1990年 | 82篇 |
1989年 | 73篇 |
1988年 | 66篇 |
1987年 | 66篇 |
1986年 | 50篇 |
1985年 | 58篇 |
1984年 | 41篇 |
1983年 | 45篇 |
1982年 | 26篇 |
1981年 | 46篇 |
1979年 | 44篇 |
1978年 | 41篇 |
1977年 | 36篇 |
1976年 | 23篇 |
1975年 | 32篇 |
1974年 | 47篇 |
1973年 | 27篇 |
1970年 | 21篇 |
1969年 | 21篇 |
排序方式: 共有3329条查询结果,搜索用时 22 毫秒
131.
Cono‐spondylar dysplasia: Clinical,radiographic, and molecular findings of a previously unreported disorder
下载免费PDF全文
![点击此处可从《American journal of medical genetics. Part A》网站下载免费的PDF全文](/ch/ext_images/free.gif)
132.
133.
Clara Unger Peter Bronsert Kerstin Michalski Anna Bicker Ingolf Juhasz-Bss 《Geburtshilfe und Frauenheilkunde》2022,82(1):50
Background Prostate specific membrane antigen (PSMA) is a promising protein for breast cancer patients. It has not only been detected in prostate cancer but is also expressed by tumor cells and the endothelial cells of tumor vessels in breast cancer patients. PSMA plays a role in tumor progression and tumor angiogenesis. For this reason, a number of diagnostic and therapeutic methods to target PSMA have been developed. Method This paper provides a general structured overview of PSMA and its oncogenic potential, with a special focus on its role in breast cancer. This narrative review is based on a selective literature search carried out in PubMed and the library of Freiburg University Clinical Center. The following key words were used for the search: “PSMA”, “PSMA and breast cancer”, “PSMA PET/CT”, “PSMA tumor progression”. Relevant articles were explicitly read through, processed, and summarized. Conclusion PSMA could be a new diagnostic and therapeutic alternative, particularly for triple-negative breast cancer. It appears to be a potential predictive and prognostic marker. Key words: PSMA, breast cancer, radioligand therapy, immunohistochemistry, PET/CT
Abbreviations
- CT
- computed tomography
- ER
- estrogen receptor
- FOLH1
- folate hydrolase 1
- FDG
- fluorodeoxyglucose
- GCPI
- glutamate carboxypeptidase II
- HR
- hormone receptor
- HUVEC
- human umbilical vein endothelial cell
- n. s.
- not significant
- PET
- positron emission tomography
- PR
- progesterone receptor
- PSMA
- prostate specific membrane antigen
- TNBC
- triple-negative breast cancer
- SUV
- standardized uptake value
- VEGF
- vascular endothelial growth factor
134.
Lahner H. Fendler W. P. Theurer S. Unger N. Herrmann K. Schmid K. W. Führer D. 《Best Practice Onkologie》2020,15(7-8):320-333
best practice onkologie - Neuroendokrine Neoplasien (NEN) des Verdauungstrakts stellen eine heterogene Erkrankung mit variabler klinischer Manifestation dar. Sie machen etwa 1 % aller... 相似文献
135.
Grant R. Williams Kathryn E. Weaver Glenn J. Lesser Emily Dressler Karen M. Winkfield Heather B. Neuman Anne E. Kazak Ruth Carlos Lucy J. Gansauer Charles S. Kamen Joseph M. Unger Supriya G. Mohile Heidi D. Klepin 《The oncologist》2020,25(12):1032-1038
BackgroundAmerican Society of Clinical Oncology guidelines recommend that patients ≥65 years of age starting chemotherapy undergo a geriatric assessment (GA) to inform and guide management; however, little is known about resources available in community oncology practices to implement these guidelines and to facilitate geriatric oncology research.Materials and MethodsOncology practices within the National Cancer Institute Community Oncology Research Program (NCORP) were electronically surveyed in 2017 regarding the availability of specialty providers, supportive services, and practice characteristics, as part of a larger survey of cancer care delivery research capacity.ResultsOf the 943 NCORP practices, 504 (54%) responded to the survey, representing 210 practice groups. The median new cancer cases per year ≥65 years of age was 457 (interquartile range 227–939). Of respondents, only 2.0% of practices had a fellowship‐trained geriatric oncologist on staff. Geriatricians were available for consultation or comanagement at 37% of sites, and of those, only 13% had availability within the oncology clinic (5% of overall). Practice size of ≥1,000 new adult cancer cases (ages ≥18) per year was associated with higher odds (1.81, confidence interval 1.02–3.23) of geriatrician availability. Other multidisciplinary care professionals that could support GA were variably available onsite: social worker (84%), nurse navigator (81%), pharmacist (77%), dietician (71%), rehabilitative medicine (57%), psychologist (42%), and psychiatrist (37%).ConclusionOnly a third of community oncology practices have access to a geriatrician within their group and only 5% of community sites have access within the oncology clinic. Use of primarily self‐administered GA tools that direct referrals to available services may be an effective implementation strategy for guideline‐based care.Implications for PracticeOnly a minority of community oncology practices in the U.S. have access to geriatric specialty care. Developing models of care that use patient‐reported measures and/or other geriatric screening tools to assess and guide interventions in older adults, rather than geriatric consultations, are likely the most practical methods to improve the care of this vulnerable population. 相似文献
136.
王文志 杨定焯 蒋建军 吴涛 程晓光 周琦 卓铁军 张华俦 项静 王洪复 区品中 刘建立 徐苓 黄公怡 黄琪仁 HS Barden LS Weynan KG Fqukner 孟迅吾 《中国神经再生研究》2008,12(50):9997-10000
背景: 不同地区骨峰值和标准差不同,对骨质疏松诊断率有较大影响。探讨建立一完整数据库为中国人骨质疏松诊断准确性提供依据。
目的:探讨青年人腰椎骨密度和标准差正常参考值影响骨质疏松症检出率的程度。
设计、时间及地点:调查分析,于1997-01/1999-12分别在北京、上海、广州、南京、嘉兴和成都市完成。
对象:采用前瞻性及回顾性方法对全国6个中心骨密度参考数据库中11 418人进行调查统计分析;男3 666人,女7 752人;年龄20岁~90岁;分别来自北京(2 385人)、广州(1 178人)、上海(1 404人)、南京(2 938人)、成都(1 425人)、嘉兴(2 088人),受试者来源于社区调查、健康体检和健康志愿者。
方法:用GE-Lunar公司的DXA仪测量骨密度,调查全国6个中心11 418人L2~L4腰椎后前位和髋部骨密度,建立了骨密度参考数据库。6个中心的仪器内部精度0.3%~0.7%,仪器间的精度1.1%。
主要观察指标:①6个中心不同年龄组腰椎骨密度分布。②青年人群骨密度及其标准差值对骨质疏松症检出率的影响。
结果:中国汉族女性以腰椎进行骨质疏松症诊断的青年人群的骨密度和标准差值,6个中心,最大差值分别为0.098 g/cm2和0.027 g/cm2。用6个中心及总体各自的青年人平均骨密度和标准差值为参考标准,对同一人群计算T-score和获得的骨质疏松症检出率不相同;发现青年人平均骨密度每变化0.01 g/cm2,则骨质疏松症检出率变化1.6%(呈正相关),其标准差值每变化 0.01 g/cm2,则骨质疏松症检出率变化4%(呈负相关)。
结论:青年人平均骨密度和标准差值不同引起骨质疏松症检出率也不相同。为了让不同中心的骨质疏松症检出率有可比性,建议同一个类型的骨密度仪,同一个种族,同一个地区用一个设计较完善大样本的参考数据库,以其青年人正常参考值计算T-score。 相似文献
137.
Thomas Unger Peter J. Horst Martin Bauer Gudrun Demmert Rainer Rettig Peter Rohmeiss 《Brain research》1989,486(1):33-38
The effects of intracerebroventricular (i.c.v.) injections of angiotensin II (ANG II, 10 pg, 100 pg and 10 ng) on renal sodium excretion were investigated in conscious rats instrumented with a chronic urethral catheter. ANG II increased renal sodium excretion dose-dependently with a threshold i.c.v. dose of 10 pg. Only after the highest dose was a concomitant increase in arterial blood pressure and urinary flow observed. The ANG II-induced natriuresis began within 5 min of the i.c.v. injection and lasted for more than 1 h. The angiotensin receptor antagonist saralasin (1 ng, i.c.v.) largely prevented the natriuretic effect of i.c.v. injected ANG II (100 pg). Our results lend further support to the hypothesis that brain ANG II by its potent natriuretic actions may be instrumental in central osmotic control. 相似文献
138.
Shuji Mizumoto Andreas R. Janecke Azita Sadeghpour Gundula Povysil Marie T. McDonald Sheila Unger Susanne Greber‐Platzer Kristen L. Deak Nicholas Katsanis Andrea Superti‐Furga Kazuyuki Sugahara Erica E. Davis Shuhei Yamada Julia Vodopiutz 《Human mutation》2020,41(3):655-667
Congenital disorders of glycosylation (CDGs) comprise a large number of inherited metabolic defects that affect the biosynthesis and attachment of glycans. CDGs manifest as a broad spectrum of disease, most often including neurodevelopmental and skeletal abnormalities and skin laxity. Two patients with biallelic CSGALNACT1 variants and a mild skeletal dysplasia have been described previously. We investigated two unrelated patients presenting with short stature with advanced bone age, facial dysmorphism, and mild language delay, in whom trio‐exome sequencing identified novel biallelic CSGALNACT1 variants: compound heterozygosity for c.1294G>T (p.Asp432Tyr) and the deletion of exon 4 that includes the start codon in one patient, and homozygosity for c.791A>G (p.Asn264Ser) in the other patient. CSGALNACT1 encodes CSGalNAcT‐1, a key enzyme in the biosynthesis of sulfated glycosaminoglycans chondroitin and dermatan sulfate. Biochemical studies demonstrated significantly reduced CSGalNAcT‐1 activity of the novel missense variants, as reported previously for the p.Pro384Arg variant. Altered levels of chondroitin, dermatan, and heparan sulfate moieties were observed in patients’ fibroblasts compared to controls. Our data indicate that biallelic loss‐of‐function mutations in CSGALNACT1 disturb glycosaminoglycan synthesis and cause a mild skeletal dysplasia with advanced bone age, CSGALNACT1‐CDG. 相似文献
139.
Daniel P. Potaczek Sebastian D. Unger Nan Zhang Styliani Taka Sven Michel Nesibe Akdağ Feng Lan Markus Helfer Christoph Hudemann Markus Eickmann Chrysanthi Skevaki Spyridon Megremis Anne Sadewasser Bilal Alashkar Alhamwe Fahd Alhamdan Mübeccel Akdis Michael R. Edwards Sebastian L. Johnston Harald Renz 《The Journal of allergy and clinical immunology》2019,143(4):1403-1415
140.